To understand the diversity and abundance of antibiotic resistance genes (ARGs) in pharmaceutical wastewater treatment bioreactors, the ARGs in sludge from two full-scale pharmaceutical wastewater treatment plants (PWWTPs) were investigated and compared with sludge samples from three sewage treatment plants (STPs) using metagenomic approach. The results showed that the ARG abundances in PWWTP sludge ranged from 54.7 to 585.0 ppm, which were higher than those in STP sludge (27.2 to 86.4 ppm).

Deaths caused by AIDS declined nearly 55% in India in the past eight years, whereas new HIV infections came down by 66% since 2000.

This report provides guidance for countries to enhance the functioning and transparency of the patent system for the timely and affordable access to lifesaving treatment. Affordable access to treatment is closely linked with the aspiration to ensure health and well-being for all, as embodied in the Sustainable Development Goal (SDG).

Products of major pharmaceutical firms, including Abbott Healthcare, Cipla and Lupin will be affected by the new price cap

Dishman Pharma Poonam Khetrapal Singh said in India, we would need to think of new ways in which the health care services are rendered.

New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access, prompting wide debate about fair and affordable prices. This study systematically compared the price and affordability of sofosbuvir and ledipasvir/sofosbuvir across 30 countries to assess affordability to health systems and patients.

Original Source

What are we to do about antibiotic resistance? Last week, another government report repeated stark warnings about the crisis, and offered some suggestions to improve the situation. The UK report, prepared by a panel chaired by the economist Jim O'Neill, naturally focused on financial incentives, including US$1-billion prizes for pharmaceutical firms that develop new antimicrobial drugs.

Original Source

French drug and vaccines giant Sanofi suffered a setback in introducing its muchawaited dengue vaccine Dengvaxia in India after a top health ministry committee rejected its request to waive additio

VISAKHAPATNAM: The government is planning to introduce a new policy to ensure better coordination between the APPCB and pharma companies to bring down pollution levels, said Andhra Pradesh Pollutio

After 2010, two Indian generic companies started local plants in South Africa, attempted to partake in the morally loaded politics of antiretroviral therapy, and complied with broader affirmative action policies there. This article analyses a variety of sources and tries to lay bare the nexus between drug manufacturers, the state, and civil society organisations and tries to contextualise them in the anthropological theories of public health and humanitarian aid.

Pages